NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Hoffmann-La Roche
AstraZeneca
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
AstraZeneca
AstraZeneca
Exelixis
AstraZeneca
AstraZeneca
AstraZeneca
Sanofi
Exelixis
Verrica Pharmaceuticals Inc.
Pfizer
Hoffmann-La Roche
Numab Therapeutics AG
Regeneron Pharmaceuticals
HiberCell, Inc.
Boston Scientific Corporation
Intensity Therapeutics, Inc.
Sirtex Medical
Atara Biotherapeutics
BeiGene
Imunon
Advaxis, Inc.
Kyowa Kirin Co., Ltd.
MedImmune LLC
Novartis
Nektar Therapeutics
Pfizer
Takeda
Karyopharm Therapeutics Inc
Amgen
Takeda
Hoffmann-La Roche
UroGen Pharma Ltd.
Eli Lilly and Company
Eli Lilly and Company
Symphogen A/S
Pfizer
Mereo BioPharma
Rexahn Pharmaceuticals, Inc.
GlaxoSmithKline
AstraZeneca
Acrotech Biopharma Inc.
Merck Sharp & Dohme LLC
Eli Lilly and Company
Eli Lilly and Company
Pfizer